T2 Biosystems, Inc. Net Change in Cash
T2 Biosystems, Inc. reported Net Change in Cash of -$13.61 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-11-14
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$9.48M.
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$1.21M.
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$13.27M.
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$6.10M, a 124.13% decline year-over-year.
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $4.36M.
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$11.92M, a 284.69% decline from fiscal 2021.
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $6.45M, a 5.24% increase from fiscal 2020.
- T2 Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $6.13M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$13.61M 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -$11.44M 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | -$9.48M 10-Q · filed 2024-05-06 | |||
| 2023-12-31 | $4.36M 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $12.99M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $4.75M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$1.21M 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | -$11.92M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$2.30M 10-Q · filed 2023-11-15 | |||
| 2022-06-30 | -$9.45M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$13.27M 10-Q · filed 2023-05-22 | |||
| 2021-12-31 | $6.45M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $6.25M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $15.91M 10-Q · filed 2022-08-16 | |||
| 2021-03-31 | -$6.10M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $6.13M 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $8.40M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $15.50M 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $25.29M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$39.77M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | -$34.59M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$22.38M 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | -$13.40M 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $8.93M 10-K · filed 2020-03-16 | |||
| 2018-09-30 | $18.35M 10-Q · filed 2019-11-18 | |||
| 2018-06-30 | $28.83M 10-Q · filed 2019-08-02 | |||
| 2018-03-31 | -$12.15M 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | -$31.69M 10-K · filed 2020-03-16 | |||
| 2017-09-30 | -$20.59M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | -$27.35M 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | -$14.67M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$174.00K 10-K · filed 2019-03-14 |